5 ms·
Around 20% of all biotech revenue gets put back into R&D. So the next time your insurance pays $1000 for a drug, know that $200 of that goes back to R&D.
by refurb 7y ago
Around 20% of all biotech revenue gets put back into R&D.
So the next time your insurance pays $1000 for a drug, know that $200 of that goes back to R&D.
- cma 7y agoThe rest largely funds more fireworks at the Super Bowl through consumer targeted drug ads, and lunches to manipulate doctors into prescribing based on soft bribery.
- sudosysgen 7y agoAnd a significant part of R&D is in practice patent-engineering and slightly better solution to trivially solved issues.